Boston Scientific Corporation has acquired Cosman Medical a privately-held manufacturer of radiofrequency ablation systems. According to a press release, the Cosman Medical team and products will become part of the Boston Scientific Neuromodulation business.
“This acquisition is a natural extension of our current product portfolio and will help us provide physicians and patients more options to address chronic pain with non-opioid therapeutic treatments,” says Maulik Nanavaty, senior vice president and president, Neuromodulation, Boston Scientific.
“We are pleased to join the Boston Scientific team and help expand access to leading treatments for chronic pain,” says Eric Cosman, scientific director, Cosman Medical.
The expansion into radiofrequency ablation follows the recent Boston Scientific launch of the Precision Montage MRI spinal cord stimulator system, designed to offer customised relief to patients with chronic pain, while enabling safe access to full body magnetic resonance imaging (MRI) in a 1.5 Tesla environment when conditions of use are met. MultiWave technology is designed to enable delivery of multiple waveforms, including burst and higher rates, intended to help respond to changes in pain over time.
Boston Scientific currently expects the net impact of this transaction on adjusted earnings-per-share to be break-even in 2016 and accretive thereafter and more dilutive on a GAAP basis as a result of acquisition-related net charges and amortisation. Specific terms of the transaction were not disclosed.